Unknown NA INTERVENTIONAL NCT01636674

18F-FDG PET/CT and Molecular Tumor Characterisation for Staging and Follow-up of Colon Cancer (COLOPET1)

Value of 18F-Fluordeoxyglucose Positron Emission Tomography/ Computed Tomography and Molecular Tumor Characterisation in Preoperative Staging og Postoperative Control of Colon Cancer

Sponsor: Naestved Hospital

Conditions Colon Cancer

Interventions 18F-fluordeoxyglucose positron emission tomography/ computed tomography

Updated 5 times since 2017 Last updated: Jul 9, 2012 Started: Jul 31, 2009 Primary completion: Mar 31, 2013 Completion: Mar 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Colon Cancer and is currently ongoing. Naestved Hospital leads this study, which shows 5 recorded versions since 2009 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Jul 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Naestved Hospital
Region Zealand
Rigshospitalet, Denmark
University of Copenhagen

Data source: Naestved Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.